Mar. 24, 2023
PYR01: A Path Forward for HIV Eradication?
PYR01
bifunctional, Gag-Pol allosteric glue NNRTI + nanomolar ex vivo HIV-1 TACK activity HTS of >6K NNRTIs for TACK activity Sci. Transl. Med., February 22, 2023 Merck & Co. Inc., Rahway, NJ
bifunctional, Gag-Pol allosteric glue NNRTI + nanomolar ex vivo HIV-1 TACK activity HTS of >6K NNRTIs for TACK activity Sci. Transl. Med., February 22, 2023 Merck & Co. Inc., Rahway, NJ